InspireMD, Inc.
(NASDAQ : NSPR)

( )
NSPR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.74%592.351.0%$762.53m
DHRDanaher Corp. 1.47%308.650.7%$673.27m
ABTAbbott Laboratories 2.29%119.490.8%$616.30m
MDTMedtronic Plc 1.27%122.250.6%$530.48m
ISRGIntuitive Surgical, Inc. 1.20%336.300.8%$342.61m
ALGNAlign Technology, Inc. -0.15%594.276.3%$329.63m
BDXBecton, Dickinson & Co. 1.85%242.861.0%$316.84m
DXCMDexCom, Inc. 1.62%550.057.8%$281.32m
SYKStryker Corp. 3.35%270.841.3%$270.77m
EWEdwards Lifesciences Corp. 3.57%115.060.4%$260.36m
BSXBoston Scientific Corp. 3.15%44.151.0%$255.17m
IDXXIDEXX Laboratories, Inc. 0.42%640.993.8%$249.05m
AAgilent Technologies, Inc. 0.59%155.691.6%$219.15m
BAXBaxter International, Inc. 1.88%79.651.8%$189.26m
INMDInMode Ltd. -0.29%84.770.0%$181.73m

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.